XEU:CA:TSX-iShares MSCI Europe IMI (CAD)

ETF | European Equity |

Last Closing

CAD 30.87

Change

-0.02 (-0.06)%

Market Cap

CAD 0.32B

Volume

3.78K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-07 )

Largest Industry Peers for European Equity

Symbol Name Price(Change) Market Cap
ZEQ:CA BMO MSCI Europe High Quality C..

-0.08 (-0.26%)

CAD 1.11B
ZWP:CA BMO Europe High Dividend Cover..

-0.03 (-0.16%)

CAD 0.78B
ZWE:CA BMO Europe High Dividend Cover..

-0.06 (-0.29%)

CAD 0.59B
VE:CA Vanguard FTSE Developed Europe..

N/A

CAD 0.20B
XEH:CA iShares MSCI Europe IMI Index ..

+0.13 (+0.40%)

CAD 0.14B
RPD:CA RBC Quant European Dividend Le..

N/A

CAD 0.03B
EDGF:CA Brompton European Dividend Gro..

+0.05 (+0.47%)

CAD 0.02B
RPDH:CA RBC Quant European Dividend Le..

N/A

CAD 0.01B
EHE:CA CI Europe Hedged Equity Index ..

N/A

CAD 1.61M
HXX:CA Global X Europe 50 Index Corpo..

+0.05 (+0.10%)

N/A

ETFs Containing XEU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (European Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.39% 73% C 47% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.39% 73% C 47% F
Trailing 12 Months  
Capital Gain 19.14% 73% C 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 19.14% 73% C 50% F
Trailing 5 Years  
Capital Gain 34.98% 82% B 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.98% 82% B 60% D-
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.32B 70% C- 52% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.